Figures & data
Table 1 Correlations of hypermethylation of SFRPs gene promoter with clinical features in non-M3 AML patients
Table 2 Primer sequences of SFRPs for RQ-PCR and RQ-MSP
Figure 1 Electrophoresis results of RQ-MSP products in leukemic cell lines.
![Figure 1 Electrophoresis results of RQ-MSP products in leukemic cell lines.](/cms/asset/9977474d-d961-459a-8fb4-b8be92cc2d79/dott_a_12195538_f0001_b.jpg)
Figure 2 Electrophoresis results of RQ-MSP products of SFRPs in AML patients.
Abbreviations: RQ-MSP, real-time quantitative methylation-specific polymerase chain reaction; SFRPs, secreted frizzled-related proteins; AML, acute myeloid leukemia; M, methylation; U, unmethylation.
![Figure 2 Electrophoresis results of RQ-MSP products of SFRPs in AML patients.](/cms/asset/3bf1d9fc-55c1-44dd-bfaa-25a6dd452e0b/dott_a_12195538_f0002_b.jpg)
Figure 3 Overall survival of non-M3 AML patients: (A) all patients; (B) cytogenetically normal patients.
![Figure 3 Overall survival of non-M3 AML patients: (A) all patients; (B) cytogenetically normal patients.](/cms/asset/bbebc290-5eb5-4f27-b507-9bad70af1af6/dott_a_12195538_f0003_c.jpg)
Figure 4 HL60 with 5-aza-dC treatment.
Abbreviations: 5-aza-dC, 5-aza-2′-deoxycytidine; RQ-PCR, real-time quantitative polymerase chain reaction; RQ-MSP, real-time quantitative methylation-specific polymerase chain reaction.
![Figure 4 HL60 with 5-aza-dC treatment.](/cms/asset/badfe9e7-154d-478c-a0a3-c39f76f0f954/dott_a_12195538_f0004_b.jpg)